Regulation of Pharmaceuticals & Medical Devices: Advanced

Regulation of Pharmaceuticals & Medical Devices: Advanced

Regulatory Affairs — Applied Drug + Device + Combination Product Strategy

Regulation of Pharmaceuticals & Medical Devices: Advanced

Move from cross-categorical foundations to applied drug-plus-device regulatory work — applied ICH GCP planning, applied EU MDR / IVDR, applied combination-product analysis, applied adverse-event reporting, and a cross-categorical strategy memo.

RAQ-510-AAdvanced32 hoursCertificate of Completion

Request information and a custom quote

Regulation of Pharmaceuticals & Medical Devices
FormatProfessional Certificate Course
LevelAdvanced
Duration32 hours
LanguageEnglish
CertificateCertificate of Completion — Aleph University
Full course trackIntroductory (16 h) + Advanced (32 h) = 48 hours
Prerequisite / Recommended Preparation

Recommended prerequisite: completion of the Introductory level for this training, or relevant professional experience subject to Aleph University review.

Overview

The Advanced level of the Aleph Regulation of Pharmaceuticals & Medical Devices course track is for professionals who already know both regulatory worlds at orientation depth and need to develop the applied skills that cross-categorical RA work demands: planning a clinical investigation under ICH GCP and the applicable U.S. clinical-investigation regulations; applying the EU MDR and EU IVDR to a device submission and the EU centralised pharmaceutical procedure to a drug submission; analyzing a combination product under the FDA Office of Combination Products framework with Primary Mode of Action determination; conducting applied analysis on the MAUDE and FAERS adverse-event databases; and authoring a cross-categorical strategy memo that handles a real product spanning drugs and devices.

This 32-hour Professional Certificate Course builds directly on the 16-hour Introductory level (`RAQ-510-I`). It does not repeat the orientation material. Where the Introductory level identifies IND and IDE, the Advanced level constructs a clinical-investigation plan under each. Where the Introductory level identifies MAUDE and FAERS, the Advanced level conducts hands-on queries against both. The course culminates in a cross-categorical regulatory analysis course exercise — a portfolio-grade artifact in which the participant chooses a product (typically a combination product), constructs a parallel FDA and EMA strategy, and lays out the clinical-evidence plan that satisfies both jurisdictions.

What you will learn
Apply the FDA drug-development pathway (IND under 21 CFR Part 312; NDA under 21 CFR Part 314; BLA for biologics) to a real product scenario.
Apply the FDA device-development pathway (Design Controls; 510(k); De Novo; PMA; IDE under 21 CFR Part 812) to a real product scenario.
Plan a clinical investigation under ICH E6(R3) Good Clinical Practice with the applicable U.S. regulations (21 CFR Parts 50, 56).
Apply EU MDR and EU IVDR to a device submission and the EU centralised pharmaceutical procedure to a drug submission.
Analyze a combination product under the FDA Office of Combination Products framework and determine the Primary Mode of Action.
Conduct applied analysis using the FDA MAUDE database (for devices) and FAERS (for pharmaceuticals), and meet the MedWatch reporting requirements.
Justify cross-jurisdictional regulatory pathway decisions with citations to primary sources.
Author a cross-categorical strategy memo for a chosen drug-and-device product as a portfolio-grade course artifact.
course topics & modules
Professional relevance

Graduates of the Advanced course are positioned for applied work in cross-categorical Regulatory Affairs roles at integrated health-product manufacturers, at combination-product companies, at contract research organizations, in pharmacovigilance and post-market surveillance specialists, and at consultancies serving cross-categorical clients. The cross-categorical strategy memo produced during the course is a portfolio-grade artifact that demonstrates the participant’s ability to think strategically across drug and device worlds and across FDA and EU jurisdictions.

Certificate of Completion

Participants who meet the course completion requirements receive a Certificate of Completion issued by Aleph University.

Completion of both the Introductory and Advanced levels may be reviewed by Aleph University for potential recognition within an applicable graduate pathway, subject to institutional review and applicable academic policies. Recognition is not automatic and is not guaranteed.
Frequently asked questions
Ready to discuss this course?

Tell us about your goals, audience, and timeline. Aleph University will follow up with information and a custom quote for individuals, teams, or organizations.

Available for individual participants and organization-based learning.